BP Dec 2024 42.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

6.80

+0.95

(+16.24%)

At close: 03:36PM EDT

Loading interactive chart…

Zacks
Top Analyst Reports for Abbott, BP & Gilead
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Smith-Midland Corporation (SMID) and Crimson Wine Group, Ltd. (CWGL).
Zacks
BP to Acquire Full Control of Biofuels Joint Venture for $1.4B
BP has agreed to buy Bunge's 50% interest in their joint venture (JV), BP Bunge Bioenergia. The $1.4 billion deal will give BP full ownership of the JV, enabling streamlined operations and a refined focus on profitable biofuel developments.
Zacks
BP p.l.c. (BP) is Attracting Investor Attention: Here is What You Should Know
BP (BP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.